Literature DB >> 8299728

Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions.

N Zini1, S Santi, A Ognibene, A Bavelloni, L M Neri, A Valmori, E Mariani, C Negri, G C Astaldi-Ricotti, N M Maraldi.   

Abstract

Monoclonal antibodies raised against DNA topoisomerase I and against topoisomerase II alpha and beta isoforms, which have been previously demonstrated to be highly specific and capable of detecting cell cycle-related variations of the topoisomerase II isoforms (Negri et al., 1992, Exp. Cell Res. 200, 452-459), have been utilized for a fine subcellular localization. Immunocytochemistry by confocal and electron microscopy have been used for a topological and quantitative evaluation of the fine distribution of the different topoisomerases in HeLa and K562 cells. Topoisomerase I and topoisomerase II alpha are present both in the nucleoplasm and in the nucleolus, though at different relative ratios, while topoisomerase II beta is exclusively present at the nucleolar level. This is further confirmed by immunoblotting and immunocytochemical quantitative evaluations performed on purified nuclear matrix fractions obtained from K562 cells. In fact, the amount of topoisomerase I and topoisomerase II alpha present in the whole cell nuclei is partly lost in isolated nuclei but, while topoisomerase I is further significantly reduced in nuclear matrix preparations, the topoisomerase II alpha content is only slightly decreased. On the other hand, the great majority of topoisomerase II beta is retained in the nuclear matrix and can be detected exclusively in association with the nucleolar remnant. These results are consistent with specific functional roles hypothesized for the different topoisomerase types.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299728     DOI: 10.1006/excr.1994.1046

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain.

Authors:  N Adachi; M Miyaike; S Kato; R Kanamaru; H Koyama; A Kikuchi
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

2.  Protein kinase C isoenzymes in mouse harderian gland. Differential expression of the alpha- and epsilon-isoforms during pregnancy. Protein kinase C-OC.

Authors:  V Grill; A M Martelli; R Bareggi; S Santi; M Basa; M Zweyer; L Cocco; P Narducci
Journal:  Histochem Cell Biol       Date:  1995-04       Impact factor: 4.304

3.  The effect of sodium tetrathionate stabilization on the distribution of three nuclear matrix proteins in human K562 erythroleukemia cells.

Authors:  L M Neri; B M Riederer; R A Marugg; S Capitani; A M Martelli
Journal:  Histochem Cell Biol       Date:  1995-07       Impact factor: 4.304

4.  Quantitative confocal spectral imaging analysis of mitoxantrone within living K562 cells: intracellular accumulation and distribution of monomers, aggregates, naphtoquinoxaline metabolite, and drug-target complexes.

Authors:  A Feofanov; S Sharonov; F Fleury; I Kudelina; I Nabiev
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

5.  Bioflavonoids as poisons of human topoisomerase II alpha and II beta.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Biochemistry       Date:  2007-04-26       Impact factor: 3.162

Review 6.  Bioinformatic analysis of the nucleolus.

Authors:  Anthony K L Leung; Jens S Andersen; Matthias Mann; Angus I Lamond
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

7.  Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin.

Authors:  Ian G Cowell; Nikolaos Papageorgiou; Kay Padget; Gary P Watters; Caroline A Austin
Journal:  Nucleus       Date:  2011 Jan-Feb       Impact factor: 4.197

8.  Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.

Authors:  K N Meyer; E Kjeldsen; T Straub; B R Knudsen; I D Hickson; A Kikuchi; H Kreipe; F Boege
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

9.  Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

Authors:  S Withoff; E G de Vries; W N Keith; E F Nienhuis; W T van der Graaf; D R Uges; N H Mulder
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

10.  Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines.

Authors:  E W Eijdems; M de Haas; A J Timmerman; G P Van der Schans; E Kamst; J de Nooij; G C Astaldi Ricotti; P Borst; F Baas
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.